Belgium· BE-AMP-SAM157421-00
Rydene IV 1 mg/ml
A nicardipine product containing nicardipine hydrochloride, registered in Belgium by Laboratoire X.O. The same ATC class is registered in 8 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Nicardipine is registered in 8 of 19 countries.
Countries holding a registration under ATC C08CA04 (nicardipine), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 5 of them publish a price we can compare per daily dose
Nicardipine · ATC C08CA04
8 / 19 countries
- Belgiumprice
- Franceprice
- Japan
- Netherlands
- Norwayprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Nicardipine Hydrochloride
- Manufacturer
- Laboratoire X.O
- Country
- Belgium (BE)
- ATC code
- C08CA04
- ATC class
- Nicardipine
- Defined daily dose
- 90 mg, O
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 4
- be_apb0743021
- be_apb1189836
- be_apb4636072
- be_apb7747504
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
228 interactions on record for nicardipine.
Graded by severity as the source publishes them — 8 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Nicardipine · interactions on record
228 records
- 8 severe
- 173 moderate
- 1 minor
- 46 info
Most severe, free to view
- DolasetronA04AA04severe
- CeritinibL01ED02severe
- CeritinibL01XE28severe
- MitotaneL01XX23severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Nicardipine in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainVASONASE 1 mg/ml SOLUCIÓN PARA PERFUSIÓNLaboratoire X.O
- NetherlandsCardene IV, 1 mg/ml oplossing voor infusieLaboratoire X.O.
- United StatesCardene IVBaxter Healthcare Corporation
- United KingdomCardene 20mg capsulesDowelhurst Ltd
- FranceLOXEN 10 mg/10 mL, solution injectable (I.V.)LABORATOIRE XO
- SwitzerlandNicardipin Aguettant 10 mg/10 ml, solution injectableAguettant Suisse SA
- ItalyNICARDIPINA*30 cps 40 mg rilascio prolungatoMYLAN SpA
- NorwayNicardipine HCl hikmaHikma
Authorised across Europe · EMA
The same active substance is authorised in 6 EEA countries. Names it is sold under:
- Spain · Flusemide, Nerdipina Retard
- France · Loxen, Loxen Lp
- United Kingdom (Northern Ireland) · Nicardipine Hydrochloride Tillomed Laboratories, Nicardipine Laboratoire Aguettant
- Italy · Nicardipina Mylan Generics
- Luxembourg · Nicardipine Aguettant, Rydene Iv
- Netherlands · Cardene Iv
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/524adeb8-5810-44ec-9fe9-3428a6fe4b90 GET /v1/drugs/524adeb8-5810-44ec-9fe9-3428a6fe4b90?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for infusion",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Rydene IV 1 mg/ml",
"name_fr": "Rydene IV 1 mg/ml",
"name_nl": "Rydene IV 1 mg/ml",
"amp_code": "SAM157421-00",
"strengths": [
"5.0000",
"250.0000"
],
"pack_count": 4,
"substances": [
"Nicardipine Hydrochloride",
"Sorbitol"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Nicardipine",
"authorisation_numbers": [
"BE157421"
]
}See everything about nicardipine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.